Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176897 | SCV000228663 | uncertain significance | not provided | 2014-12-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000176897 | SCV000760362 | likely benign | not provided | 2023-11-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001842790 | SCV001357936 | likely benign | Cardiac arrhythmia | 2019-07-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345613 | SCV002652922 | likely benign | Cardiovascular phenotype | 2019-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001842790 | SCV004818618 | likely benign | Cardiac arrhythmia | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001698992 | SCV001925018 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000176897 | SCV001970573 | likely benign | not provided | no assertion criteria provided | clinical testing |